BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28982856)

  • 21. [Ph1-positive leukemia: cytogenetic outline and prognosis].
    Misawa S
    Nihon Rinsho; 1992 Jun; 50(6):1274-80. PubMed ID: 1518145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Bille A; Fryer K; Wallace A; Nonaka D
    J Clin Pathol; 2024 Jan; 77(2):125-127. PubMed ID: 36600564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrastructural characteristics of bone marrow in patients with hematological disease: a study of 13 cases.
    Ru YX; Zhao SX; Liu EB; Yang QY; Liu JH; Pang TX; Chen HS
    Ultrastruct Pathol; 2007; 31(5):327-32. PubMed ID: 17963181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia.
    Winfield DA; Polacarz SV
    J Clin Pathol; 1992 Oct; 45(10):855-9. PubMed ID: 1430254
    [No Abstract]   [Full Text] [Related]  

  • 26. Fluorescence in situ hybridization in leukemias: 'the FISH are spawning!'.
    Bentz M; Döhner H; Cabot G; Lichter P
    Leukemia; 1994 Sep; 8(9):1447-52. PubMed ID: 8090024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics: written in blood.
    DeWeerdt S
    Nature; 2013 Jun; 498(7455):S4-6. PubMed ID: 23803948
    [No Abstract]   [Full Text] [Related]  

  • 28. Gene mutation may signal indolent thymus cancer.
    Cancer Discov; 2014 Sep; 4(9):OF4. PubMed ID: 25185203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G-CSF for chromosome analysis of myeloid leukemias and MDS.
    Tsuchiya H; Higuchi S; Asou N; Yamaguchi K; Matsuda I; Yokoyama Y; Murakami T; Kaneko Y
    Cancer Genet Cytogenet; 1990 Jul; 47(2):277-9. PubMed ID: 1694102
    [No Abstract]   [Full Text] [Related]  

  • 30. Chromosome fragility and predisposition to childhood malignancies.
    Kolialexi A; Mavrou A; Tsenghi C; Tsangaris GT; Dafermou E; Tzortzatou F; Polychronopoulou S; Haidas S; Metaxotou C
    Anticancer Res; 1998; 18(4A):2359-64. PubMed ID: 9703879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms.
    So CC; Ma ES; Wan TS; Yip SF; Chan LC
    Leuk Res; 2008 Jun; 32(6):1000-1. PubMed ID: 17980911
    [No Abstract]   [Full Text] [Related]  

  • 32. Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features.
    Lee HS; Jang HJ; Shah R; Yoon D; Hamaji M; Wald O; Lee JS; Sugarbaker DJ; Burt BM
    Clin Cancer Res; 2017 Aug; 23(16):4855-4864. PubMed ID: 28400429
    [No Abstract]   [Full Text] [Related]  

  • 33. [Leukemias and malignant lymphomas in children].
    Schmiegelow K
    Ugeskr Laeger; 1999 Apr; 161(15):2191-5. PubMed ID: 10222813
    [No Abstract]   [Full Text] [Related]  

  • 34. The dual role of HLXB9 in leukemia.
    Ferguson S; Gautrey HE; Strathdee G
    Pediatr Blood Cancer; 2011 Mar; 56(3):349-52. PubMed ID: 21069786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular cytogenetic aspects of hematological malignancies: clinical implications.
    Chen Z; Sandberg AA
    Am J Med Genet; 2002 Oct; 115(3):130-41. PubMed ID: 12407693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutant GTF2I induces cell transformation and metabolic alterations in thymic epithelial cells.
    Kim IK; Rao G; Zhao X; Fan R; Avantaggiati ML; Wang Y; Zhang YW; Giaccone G
    Cell Death Differ; 2020 Jul; 27(7):2263-2279. PubMed ID: 32034314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline ETV6 mutations and predisposition to hematological malignancies.
    Feurstein S; Godley LA
    Int J Hematol; 2017 Aug; 106(2):189-195. PubMed ID: 28555414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next-generation sequencing in thymic epithelial tumors uncovered novel genomic aberration sites and strong correlation between TMB and MSH6 single nucleotide variations.
    Chen K; Che J; Zhang X; Jin R; Xiang J; Han D; Sun Y; Gong Z; Zhang D; Li H
    Cancer Lett; 2020 Apr; 476():75-86. PubMed ID: 32061754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
    Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
    Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.